US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

77.51

-0.1900-0.24%

Post-market: 77.510.00000.00%19:53 EDT

Volume:917.78K

Turnover:70.96M

Market Cap:15.03B

PE:-20.51

High:78.45

Open:77.21

Low:76.28

Close:77.70

52wk High:84.94

52wk Low:31.77

Shares:193.86M

Float Shares:151.20M

Volume Ratio:0.46

T/O Rate:0.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7800

EPS(LYR):-3.7850

ROE:-1789.67%

ROA:-33.83%

PB:-7.20

PE(LYR):-20.48

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services

BridgeBio CEO Neil Kumar disposes of USD 5,819,364 common shares

BridgeBio Oncology Therapeutics grants inducement stock options for 32,675 shares at $8.4

Assessing BridgeBio Pharma (BBIO) Valuation After Key ATTR-CM And LGMD2I/R9 Milestones

Simply Wall St.

Southwest Airlines, Colliers International, and More Stocks See Action From Activist Investors -- Barrons.com

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live

BridgeBio Pharma Evolving Into Rare Disease Powerhouse From TTR Roots, RBC Says

MT Newswires Live

RBC Initiates BridgeBio Pharma at Outperform, Speculative Risk With $100 Price Target

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)

BridgeBio presentation shows acoramidis cuts all-cause mortality risk 45% in ATTR-CM trial extension

BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial

BridgeBio presents long-term acoramidis data showing sustained sTTR gains, stable KCCQ scores

BridgeBio presents US survey showing high ATTR-CM treatment dissatisfaction, oral dosing preferred

BridgeBio submits BBP-418 NDA to FDA

BridgeBio submits FDA NDA for BBP-418 in LGMD2I/R9

BridgeBio Pharma Inc - IF Approved, BridgeBio May Qualify for Priority Review Voucher

THOMSON REUTERS

BridgeBio Pharma Inc - Anticipates U.S. Launch of Bbp-418 in Late 2026/Early 2027

THOMSON REUTERS

BridgeBio Submits Nda to FDA for Bbp-418 for Individuals Living With Lgmd2i/R9

THOMSON REUTERS

BridgeBio Oncology Therapeutics appoints Peter Lebowitz to board; board size increases to nine directors

BridgeBio to present long-term ATTRibute-CM open-label extension data on acoramidis at ACC 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","market":"US","secType":"STK","nameCN":"BridgeBio Pharma, Inc.","latestPrice":77.51,"timestamp":1776369600000,"preClose":77.7,"halted":0,"volume":917778,"hourTrading":{"tag":"盘后","latestPrice":77.51,"preClose":77.51,"latestTime":"19:53 EDT","volume":20977,"amount":1625928.16,"timestamp":1776383636210,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002445302445302416,"floatShares":151204231,"shares":193862871,"eps":-3.78,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"04-16 16:00:00 EDT","open":77.21,"high":78.45,"low":76.28,"amount":70958703.58128,"amplitude":0.027928,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.78,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":77.7,"preHourTrading":{"tag":"盘前","latestPrice":79.1,"preClose":77.7,"latestTime":"08:50 EDT","volume":27,"amount":2126.7198,"timestamp":1776343807658,"change":1.4,"changeRate":0.018018,"amplitude":0.023166},"postHourTrading":{"tag":"盘后","latestPrice":77.51,"preClose":77.51,"latestTime":"19:53 EDT","volume":20977,"amount":1625928.16,"timestamp":1776383636210,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.45559,"impliedVol":0.4978,"impliedVolPercentile":0.244},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","floatShares":151204231,"roa":"-33.83%","roe":"-1789.67%","lyrEps":-3.784997,"volumeRatio":0.45559,"shares":193862871,"dividePrice":0,"high":78.45,"amplitude":0.027928,"preClose":77.7,"low":76.28,"week52Low":31.77,"pbRate":"-7.20","psRate":"29.93","week52High":84.94,"institutionHeld":0,"latestPrice":77.51,"eps":-3.78,"divideRate":0,"volume":917778,"delay":0,"ttmEps":-3.78,"open":77.21,"prevYearClose":76.49,"prevWeekClose":74.59,"prevMonthClose":74.26,"prevQuarterClose":74.26,"fiveDayClose":75.52,"twentyDayClose":70.12,"sixtyDayClose":77.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-24","symbol":"BBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.75,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":1},{"market":"US","date":"2026-01-12","symbol":"BBIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-10-29","symbol":"BBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-08-05","symbol":"BBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-04-29","symbol":"BBIO","fiscalQuarterEnding":"2025/03","expectedEps":1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"post","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2917,"buy":0.7083,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7083,"analysts":24,"updateTime":1775707200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBIO","date":"2026-04-15","current":-20.505291,"percent":0,"low":-20.840237,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"high":-1.291392,"avg":-9.701885,"sd":5.189789,"marketCap":15107733537},"quantilePoints":[{"date":"2021-04-23","current":-17.788493,"twenty":-20.044158,"median":-15.319812,"eighty":-12.605139,"marketCap":7982123566},{"date":"2021-04-30","current":-18.603351,"twenty":-20.019831,"median":-15.360367,"eighty":-12.635536,"marketCap":8347770201},{"date":"2021-05-07","current":-13.789937,"twenty":-20.010471,"median":-15.376486,"eighty":-12.643209,"marketCap":7170119357},{"date":"2021-05-14","current":-15.406372,"twenty":-19.984428,"median":-15.341143,"eighty":-12.662152,"marketCap":8010589313},{"date":"2021-05-21","current":-16.623722,"twenty":-19.966654,"median":-15.399488,"eighty":-12.666883,"marketCap":8643554253},{"date":"2021-05-28","current":-16.996966,"twenty":-19.882542,"median":-15.453641,"eighty":-12.671032,"marketCap":8837623692},{"date":"2021-06-04","current":-16.640949,"twenty":-19.853018,"median":-15.478579,"eighty":-12.685213,"marketCap":8652511304},{"date":"2021-06-11","current":-18.355001,"twenty":-19.83702,"median":-15.547805,"eighty":-12.695943,"marketCap":9543737883},{"date":"2021-06-18","current":-17.608513,"twenty":-19.826327,"median":-15.720083,"eighty":-12.70625,"marketCap":9155599004},{"date":"2021-06-25","current":-17.355855,"twenty":-19.798145,"median":-15.849241,"eighty":-12.735844,"marketCap":9024228922},{"date":"2021-07-02","current":-18.332032,"twenty":-19.777367,"median":-15.904573,"eighty":-12.761796,"marketCap":9531795148},{"date":"2021-07-09","current":-18.423908,"twenty":-19.765066,"median":-15.95692,"eighty":-12.777314,"marketCap":9579566087},{"date":"2021-07-16","current":-16.991224,"twenty":-19.723327,"median":-16.220389,"eighty":-12.794169,"marketCap":8834638009},{"date":"2021-07-23","current":-17.398922,"twenty":-19.661012,"median":-16.344741,"eighty":-12.805568,"marketCap":9046621550},{"date":"2021-07-30","current":-15.346079,"twenty":-19.606599,"median":-16.220389,"eighty":-12.814383,"marketCap":7979239634},{"date":"2021-08-06","current":-16.359477,"twenty":-19.514064,"median":-16.18189,"eighty":-12.819413,"marketCap":8102308897},{"date":"2021-08-13","current":-15.155951,"twenty":-19.413996,"median":-16.072735,"eighty":-12.846913,"marketCap":7506242549},{"date":"2021-08-20","current":-14.826343,"twenty":-19.396383,"median":-15.911433,"eighty":-12.877744,"marketCap":7342998248},{"date":"2021-08-27","current":-15.264813,"twenty":-19.390509,"median":-15.885226,"eighty":-12.87943,"marketCap":7560158098},{"date":"2021-09-03","current":-15.609541,"twenty":-19.381725,"median":-15.844422,"eighty":-12.892818,"marketCap":7730890670},{"date":"2021-09-10","current":-15.225502,"twenty":-19.362334,"median":-15.782487,"eighty":-12.91781,"marketCap":7540688594},{"date":"2021-09-17","current":-15.760738,"twenty":-19.298571,"median":-15.74041,"eighty":-12.954856,"marketCap":7805773377},{"date":"2021-09-24","current":-14.687242,"twenty":-19.261739,"median":-15.613092,"eighty":-12.963853,"marketCap":7274106157},{"date":"2021-10-01","current":-14.436255,"twenty":-19.249167,"median":-15.567921,"eighty":-12.97305,"marketCap":7149800864},{"date":"2021-10-08","current":-13.338568,"twenty":-19.240829,"median":-15.484501,"eighty":-13.008846,"marketCap":6606152411},{"date":"2021-10-15","current":-14.50883,"twenty":-19.223163,"median":-15.472285,"eighty":-13.010321,"marketCap":7185744563},{"date":"2021-10-22","current":-14.212484,"twenty":-19.209589,"median":-15.429341,"eighty":-13.026819,"marketCap":7038974458},{"date":"2021-10-29","current":-14.665221,"twenty":-19.182062,"median":-15.400607,"eighty":-13.07699,"marketCap":7263200057},{"date":"2021-11-05","current":-14.682487,"twenty":-19.169033,"median":-15.392604,"eighty":-13.110082,"marketCap":7860166663},{"date":"2021-11-12","current":-13.163935,"twenty":-19.157212,"median":-15.36702,"eighty":-13.11831,"marketCap":7047220624},{"date":"2021-11-19","current":-11.72602,"twenty":-19.156665,"median":-15.341143,"eighty":-13.026819,"marketCap":6277442766},{"date":"2021-11-26","current":-10.873719,"twenty":-19.154476,"median":-15.313196,"eighty":-12.990726,"marketCap":5821169083},{"date":"2021-12-03","current":-10.618028,"twenty":-19.151739,"median":-15.29719,"eighty":-12.909107,"marketCap":5684286978},{"date":"2021-12-10","current":-9.949934,"twenty":-19.124371,"median":-15.270861,"eighty":-12.826359,"marketCap":5326627285},{"date":"2021-12-17","current":-11.726583,"twenty":-19.118898,"median":-15.23911,"eighty":-12.790369,"marketCap":6277744216},{"date":"2021-12-23","current":-11.168436,"twenty":-19.083868,"median":-15.195263,"eighty":-12.709249,"marketCap":5978944198},{"date":"2021-12-31","current":-4.586153,"twenty":-19.070732,"median":-15.161189,"eighty":-12.671032,"marketCap":2455164678},{"date":"2022-01-07","current":-4.028006,"twenty":-19.0565,"median":-15.154439,"eighty":-12.635536,"marketCap":2156364660},{"date":"2022-01-14","current":-3.505602,"twenty":-19.048838,"median":-15.122688,"eighty":-12.515058,"marketCap":1876699619},{"date":"2022-01-21","current":-2.831977,"twenty":-19.029609,"median":-15.09041,"eighty":-12.457705,"marketCap":1516078908},{"date":"2022-01-28","current":-2.485541,"twenty":-18.9953,"median":-15.074503,"eighty":-12.370463,"marketCap":1330616828},{"date":"2022-02-04","current":-2.746742,"twenty":-18.971579,"median":-15.027333,"eighty":-12.230213,"marketCap":1470449348},{"date":"2022-02-11","current":-2.386559,"twenty":-18.96564,"median":-14.97631,"eighty":-12.111576,"marketCap":1277627662},{"date":"2022-02-18","current":-2.221589,"twenty":-18.952504,"median":-14.926132,"eighty":-12.015605,"marketCap":1189312386},{"date":"2022-02-25","current":-2.072926,"twenty":-18.937178,"median":-14.906468,"eighty":-11.951004,"marketCap":1166101778},{"date":"2022-03-04","current":-1.970592,"twenty":-18.912,"median":-14.885263,"eighty":-11.912854,"marketCap":1108534728},{"date":"2022-03-11","current":-2.251355,"twenty":-18.886822,"median":-14.87267,"eighty":-11.825033,"marketCap":1266475095},{"date":"2022-03-18","current":-2.923088,"twenty":-18.881348,"median":-14.833903,"eighty":-11.728443,"marketCap":1644351114},{"date":"2022-03-25","current":-2.71842,"twenty":-18.870701,"median":-14.801469,"eighty":-11.69159,"marketCap":1529217015},{"date":"2022-04-01","current":-2.846993,"twenty":-18.847315,"median":-14.776883,"eighty":-11.608067,"marketCap":1601544847},{"date":"2022-04-08","current":-2.870609,"twenty":-18.826614,"median":-14.735625,"eighty":-11.535084,"marketCap":1614829550},{"date":"2022-04-14","current":-2.881105,"twenty":-18.809449,"median":-14.718485,"eighty":-11.491836,"marketCap":1620733863},{"date":"2022-04-22","current":-2.629205,"twenty":-18.753576,"median":-14.690266,"eighty":-11.338723,"marketCap":1479030356},{"date":"2022-04-29","current":-2.105628,"twenty":-18.749985,"median":-14.681194,"eighty":-11.176698,"marketCap":1184497603},{"date":"2022-05-06","current":-1.660715,"twenty":-18.734659,"median":-14.654146,"eighty":-11.087543,"marketCap":989548848},{"date":"2022-05-13","current":-1.640886,"twenty":-18.706197,"median":-14.641584,"eighty":-11.009507,"marketCap":977733339},{"date":"2022-05-20","current":-1.886275,"twenty":-18.697156,"median":-14.5737,"eighty":-10.959651,"marketCap":1123950259},{"date":"2022-05-27","current":-1.794564,"twenty":-18.693024,"median":-14.524054,"eighty":-10.880079,"marketCap":1069303531},{"date":"2022-06-03","current":-1.789607,"twenty":-18.681019,"median":-14.50883,"eighty":-10.818731,"marketCap":1066349654},{"date":"2022-06-10","current":-1.650801,"twenty":-18.650314,"median":-14.476362,"eighty":-10.633999,"marketCap":983641094},{"date":"2022-06-17","current":-1.89619,"twenty":-18.648178,"median":-14.436255,"eighty":-10.550062,"marketCap":1129858013},{"date":"2022-06-24","current":-2.2903,"twenty":-18.647542,"median":-14.38433,"eighty":-10.458015,"marketCap":1364691247},{"date":"2022-07-01","current":-2.45885,"twenty":-18.64076,"median":-14.342591,"eighty":-10.337365,"marketCap":1465123071},{"date":"2022-07-08","current":-2.498509,"twenty":-18.63798,"median":-14.300413,"eighty":-10.289314,"marketCap":1488754088},{"date":"2022-07-15","current":-2.228333,"twenty":-18.62081,"median":-14.263271,"eighty":-10.199154,"marketCap":1327767783},{"date":"2022-07-22","current":-2.51586,"twenty":-18.605956,"median":-14.240772,"eighty":-10.029272,"marketCap":1499092658},{"date":"2022-07-29","current":-2.146537,"twenty":-18.593131,"median":-14.233652,"eighty":-9.951747,"marketCap":1279028810},{"date":"2022-08-05","current":-3.256753,"twenty":-18.574173,"median":-14.215884,"eighty":-9.132314,"marketCap":1658876197},{"date":"2022-08-12","current":-3.37608,"twenty":-18.553052,"median":-14.192196,"eighty":-4.665338,"marketCap":1719657184},{"date":"2022-08-19","current":-3.018099,"twenty":-18.523053,"median":-14.156478,"eighty":-4.072548,"marketCap":1537314224},{"date":"2022-08-26","current":-3.050114,"twenty":-18.46994,"median":-14.139769,"eighty":-3.904828,"marketCap":1553621318},{"date":"2022-09-02","current":-2.927877,"twenty":-18.431947,"median":-14.10667,"eighty":-3.545195,"marketCap":1491357868},{"date":"2022-09-09","current":-3.437199,"twenty":-18.422496,"median":-14.103623,"eighty":-3.451169,"marketCap":1750788909},{"date":"2022-09-16","current":-3.242201,"twenty":-18.414899,"median":-14.058044,"eighty":-3.370841,"marketCap":1651463882},{"date":"2022-09-23","current":-2.837654,"twenty":-18.402567,"median":-14.038583,"eighty":-3.306813,"marketCap":1445401512},{"date":"2022-09-30","current":-2.892952,"twenty":-18.38545,"median":-14.012905,"eighty":-3.236962,"marketCap":1473568311},{"date":"2022-10-07","current":-3.029741,"twenty":-18.366723,"median":-13.991375,"eighty":-3.229951,"marketCap":1543244076},{"date":"2022-10-14","current":-2.875489,"twenty":-18.362255,"median":-13.96778,"eighty":-3.214621,"marketCap":1464673532},{"date":"2022-10-21","current":-3.035562,"twenty":-18.359679,"median":-13.921816,"eighty":-3.17166,"marketCap":1546209002},{"date":"2022-10-28","current":-3.198545,"twenty":-18.35685,"median":-13.870509,"eighty":-3.161292,"marketCap":1629226935},{"date":"2022-11-04","current":-2.997162,"twenty":-18.345813,"median":-13.836853,"eighty":-3.129996,"marketCap":1470914038},{"date":"2022-11-11","current":-3.460138,"twenty":-18.3246,"median":-13.814206,"eighty":-3.104263,"marketCap":1698128402},{"date":"2022-11-18","current":-2.896647,"twenty":-18.312845,"median":-13.791224,"eighty":-3.093188,"marketCap":1421584604},{"date":"2022-11-25","current":-2.613379,"twenty":-18.311096,"median":-13.768935,"eighty":-3.082711,"marketCap":1282565289},{"date":"2022-12-02","current":-2.884464,"twenty":-18.306286,"median":-13.735517,"eighty":-3.057099,"marketCap":1415605278},{"date":"2022-12-09","current":-2.707802,"twenty":-18.292985,"median":-13.698738,"eighty":-3.038472,"marketCap":1328905061},{"date":"2022-12-16","current":-2.8205,"twenty":-18.2616,"median":-13.655724,"eighty":-3.022756,"marketCap":1384213820},{"date":"2022-12-23","current":-2.400166,"twenty":-18.250269,"median":-13.5957,"eighty":-3.011005,"marketCap":1177927095},{"date":"2022-12-30","current":-2.320973,"twenty":-18.229368,"median":-13.588886,"eighty":-2.983174,"marketCap":1139061481},{"date":"2023-01-06","current":-2.250917,"twenty":-18.22287,"median":-13.583977,"eighty":-2.971485,"marketCap":1104680360},{"date":"2023-01-13","current":-2.665159,"twenty":-18.209456,"median":-13.580361,"eighty":-2.926919,"marketCap":1307977422},{"date":"2023-01-20","current":-2.56769,"twenty":-18.202214,"median":-13.535005,"eighty":-2.907613,"marketCap":1260142819},{"date":"2023-01-27","current":-2.774811,"twenty":-18.189656,"median":-13.527444,"eighty":-2.896333,"marketCap":1361791350},{"date":"2023-02-03","current":-3.307843,"twenty":-18.183035,"median":-13.492717,"eighty":-2.894698,"marketCap":1623386835},{"date":"2023-02-10","current":-3.475367,"twenty":-18.156973,"median":-13.446485,"eighty":-2.896333,"marketCap":1705602558},{"date":"2023-02-17","current":-3.990124,"twenty":-18.132745,"median":-13.344804,"eighty":-2.896768,"marketCap":1958229055},{"date":"2023-02-24","current":-3.664917,"twenty":-18.127003,"median":-13.338568,"eighty":-2.899947,"marketCap":1763495962},{"date":"2023-03-03","current":-3.419541,"twenty":-18.104572,"median":-13.30953,"eighty":-2.90507,"marketCap":1645424988},{"date":"2023-03-10","current":-4.680888,"twenty":-18.07051,"median":-13.262445,"eighty":-2.907003,"marketCap":2252363830},{"date":"2023-03-17","current":-4.511098,"twenty":-18.064775,"median":-13.248215,"eighty":-2.909464,"marketCap":2170663577},{"date":"2023-03-24","current":-4.960543,"twenty":-18.058861,"median":-13.222467,"eighty":-2.915484,"marketCap":2386928952},{"date":"2023-03-31","current":-5.519853,"twenty":-18.051659,"median":-13.20999,"eighty":-2.925004,"marketCap":2656059196},{"date":"2023-04-06","current":-5.170284,"twenty":-18.049204,"median":-13.190521,"eighty":-2.92955,"marketCap":2487852794},{"date":"2023-04-14","current":-5.213564,"twenty":-18.039702,"median":-13.163935,"eighty":-2.936853,"marketCap":2508678348},{"date":"2023-04-21","current":-5.483231,"twenty":-18.008528,"median":-13.120004,"eighty":-2.945156,"marketCap":2638437573},{"date":"2023-04-28","current":-4.724168,"twenty":-17.996964,"median":-13.108081,"eighty":-2.969338,"marketCap":2273189385},{"date":"2023-05-05","current":-5.098963,"twenty":-17.978328,"median":-13.012532,"eighty":-2.972649,"marketCap":2166763486},{"date":"2023-05-12","current":-5.386016,"twenty":-17.960738,"median":-12.990726,"eighty":-2.974722,"marketCap":2288744245},{"date":"2023-05-19","current":-5.280259,"twenty":-17.943362,"median":-12.958206,"eighty":-2.976725,"marketCap":2243803966},{"date":"2023-05-26","current":-5.114071,"twenty":-17.928317,"median":-12.881958,"eighty":-2.980846,"marketCap":2173183526},{"date":"2023-06-02","current":-5.287813,"twenty":-17.89831,"median":-12.877744,"eighty":-2.983174,"marketCap":2247013986},{"date":"2023-06-09","current":-6.152749,"twenty":-17.895624,"median":-12.814449,"eighty":-2.997162,"marketCap":2614561273},{"date":"2023-06-16","current":-5.861919,"twenty":-17.88701,"median":-12.790369,"eighty":-3.003253,"marketCap":2490975504},{"date":"2023-06-23","current":-6.096093,"twenty":-17.84216,"median":-12.751575,"eighty":-3.008145,"marketCap":2590486123},{"date":"2023-06-30","current":-6.417139,"twenty":-17.809393,"median":-12.697254,"eighty":-3.014278,"marketCap":2726911973},{"date":"2023-07-07","current":-6.420916,"twenty":-17.792412,"median":-12.674549,"eighty":-3.01777,"marketCap":2728516983},{"date":"2023-07-14","current":-6.538004,"twenty":-17.787704,"median":-12.666883,"eighty":-3.018099,"marketCap":2778272292},{"date":"2023-07-21","current":-13.026906,"twenty":-17.752068,"median":-12.666883,"eighty":-3.019263,"marketCap":5535679455},{"date":"2023-07-28","current":-12.206209,"twenty":-17.694646,"median":-12.643182,"eighty":-3.024502,"marketCap":5186930808},{"date":"2023-08-04","current":-9.04402,"twenty":-17.681297,"median":-12.643228,"eighty":-3.032069,"marketCap":5182087735},{"date":"2023-08-11","current":-9.184326,"twenty":-17.667007,"median":-12.605139,"eighty":-3.035562,"marketCap":5262481003},{"date":"2023-08-18","current":-8.05578,"twenty":-17.651492,"median":-12.55478,"eighty":-3.036726,"marketCap":4615840855},{"date":"2023-08-25","current":-7.962207,"twenty":-17.643055,"median":-12.488397,"eighty":-3.038472,"marketCap":4562224963},{"date":"2023-09-01","current":-8.481111,"twenty":-17.638866,"median":-12.434869,"eighty":-3.042698,"marketCap":4859549454},{"date":"2023-09-08","current":-8.174872,"twenty":-17.633393,"median":-12.401532,"eighty":-3.049253,"marketCap":4684079263},{"date":"2023-09-15","current":-8.39888,"twenty":-17.624096,"median":-12.352952,"eighty":-3.051278,"marketCap":4812432458},{"date":"2023-09-22","current":-7.647461,"twenty":-17.620403,"median":-12.30172,"eighty":-3.057099,"marketCap":4381880601},{"date":"2023-09-29","current":-7.69283,"twenty":-17.613798,"median":-12.259147,"eighty":-3.061756,"marketCap":4407876184},{"date":"2023-10-06","current":-6.989615,"twenty":-17.611279,"median":-12.206209,"eighty":-3.063502,"marketCap":4004944635},{"date":"2023-10-13","current":-7.003793,"twenty":-17.6066,"median":-12.141084,"eighty":-3.072815,"marketCap":4013068255},{"date":"2023-10-20","current":-6.998122,"twenty":-17.588228,"median":-12.101539,"eighty":-3.082711,"marketCap":4009818807},{"date":"2023-10-27","current":-7.108708,"twenty":-17.566788,"median":-12.084826,"eighty":-3.083875,"marketCap":4073183042},{"date":"2023-11-03","current":-7.651953,"twenty":-17.537273,"median":-12.012885,"eighty":-3.085039,"marketCap":4687931013},{"date":"2023-11-10","current":-7.686814,"twenty":-17.526243,"median":-11.956547,"eighty":-3.088532,"marketCap":4709288097},{"date":"2023-11-17","current":-8.195103,"twenty":-17.510361,"median":-11.930684,"eighty":-3.094353,"marketCap":5020689120},{"date":"2023-11-24","current":-8.399555,"twenty":-17.494299,"median":-11.913139,"eighty":-3.097079,"marketCap":5145945398},{"date":"2023-12-01","current":-8.152509,"twenty":-17.469189,"median":-11.857337,"eighty":-3.104263,"marketCap":4994594062},{"date":"2023-12-08","current":-9.543916,"twenty":-17.429259,"median":-11.793812,"eighty":-3.115307,"marketCap":5847032617},{"date":"2023-12-15","current":-10.197026,"twenty":-17.381695,"median":-11.731234,"eighty":-3.121801,"marketCap":6247156837},{"date":"2023-12-22","current":-11.014832,"twenty":-17.355217,"median":-11.719248,"eighty":-3.129996,"marketCap":6748181947},{"date":"2023-12-29","current":-11.872393,"twenty":-17.354261,"median":-11.72602,"eighty":-3.131606,"marketCap":7273562444},{"date":"2024-01-05","current":-10.483826,"twenty":-17.341436,"median":-11.702268,"eighty":-3.143193,"marketCap":6422863559},{"date":"2024-01-12","current":-11.136935,"twenty":-17.32979,"median":-11.659423,"eighty":-3.152765,"marketCap":6822987779},{"date":"2024-01-19","current":-10.665561,"twenty":-17.326345,"median":-11.629086,"eighty":-3.155517,"marketCap":6534202473},{"date":"2024-01-26","current":-10.242459,"twenty":-17.321786,"median":-11.592759,"eighty":-3.161292,"marketCap":6274991565},{"date":"2024-02-02","current":-9.458728,"twenty":-17.298763,"median":-11.572263,"eighty":-3.166531,"marketCap":5794842502},{"date":"2024-02-09","current":-9.359342,"twenty":-17.266338,"median":-11.503758,"eighty":-3.167695,"marketCap":5733954033},{"date":"2024-02-16","current":-11.139775,"twenty":-17.227747,"median":-11.486207,"eighty":-3.17166,"marketCap":6824727449},{"date":"2024-02-23","current":-9.087803,"twenty":-17.158784,"median":-11.419175,"eighty":-3.176583,"marketCap":5845292947},{"date":"2024-03-01","current":-9.335554,"twenty":-17.077932,"median":-11.339868,"eighty":-3.183466,"marketCap":6004646954},{"date":"2024-03-08","current":-8.603155,"twenty":-17.056112,"median":-11.314907,"eighty":-3.185768,"marketCap":5533566780},{"date":"2024-03-15","current":-7.84321,"twenty":-17.050104,"median":-11.228386,"eighty":-3.189231,"marketCap":5044768381},{"date":"2024-03-22","current":-8.310648,"twenty":-17.043563,"median":-11.170649,"eighty":-3.201455,"marketCap":5345425509},{"date":"2024-03-28","current":-8.849779,"twenty":-17.040033,"median":-11.139775,"eighty":-3.213097,"marketCap":5692195694},{"date":"2024-04-05","current":-8.072628,"twenty":-17.037162,"median":-11.11833,"eighty":-3.216906,"marketCap":5192330161},{"date":"2024-04-12","current":-8.13285,"twenty":-16.996966,"median":-11.074422,"eighty":-3.224739,"marketCap":5231065129},{"date":"2024-04-19","current":-7.154958,"twenty":-16.991224,"median":-11.019807,"eighty":-3.227649,"marketCap":4602083038},{"date":"2024-04-26","current":-7.078422,"twenty":-16.989711,"median":-11.000634,"eighty":-3.233403,"marketCap":4552854895},{"date":"2024-05-03","current":-9.643939,"twenty":-16.978764,"median":-10.972094,"eighty":-3.23347,"marketCap":5190965672},{"date":"2024-05-10","current":-9.988117,"twenty":-16.973335,"median":-10.959651,"eighty":-3.242201,"marketCap":5376223639},{"date":"2024-05-17","current":-10.791199,"twenty":-16.9694,"median":-10.928667,"eighty":-3.256753,"marketCap":5808492230},{"date":"2024-05-24","current":-9.650892,"twenty":-16.924463,"median":-10.876468,"eighty":-3.271292,"marketCap":5194708257},{"date":"2024-05-31","current":-10.029835,"twenty":-16.892887,"median":-10.864916,"eighty":-3.280616,"marketCap":5398679151},{"date":"2024-06-07","current":-9.428393,"twenty":-16.866618,"median":-10.810296,"eighty":-3.285276,"marketCap":5074945531},{"date":"2024-06-14","current":-10.081983,"twenty":-16.844797,"median":-10.786611,"eighty":-3.287604,"marketCap":5426748540},{"date":"2024-06-21","current":-9.404057,"twenty":-16.814328,"median":-10.746489,"eighty":-3.296398,"marketCap":5061846483},{"date":"2024-06-28","current":-8.760896,"twenty":-16.75053,"median":-10.728734,"eighty":-3.300213,"marketCap":4715657352},{"date":"2024-07-05","current":-8.691365,"twenty":-16.630613,"median":-10.662018,"eighty":-3.300213,"marketCap":4678231500},{"date":"2024-07-12","current":-9.348432,"twenty":-16.450307,"median":-10.55255,"eighty":-3.300213,"marketCap":5031905801},{"date":"2024-07-15","current":-9.428393,"twenty":-16.387081,"median":-10.550062,"eighty":-3.300213,"marketCap":5074945531},{"date":"2024-08-02","current":-10.84727,"twenty":-15.904573,"median":-10.459746,"eighty":-3.282947,"marketCap":4922697080},{"date":"2024-08-09","current":-10.142902,"twenty":-15.794001,"median":-10.436937,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-08-16","current":-10.341782,"twenty":-15.720083,"median":-10.324027,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-08-23","current":-10.312779,"twenty":-15.554297,"median":-10.305383,"eighty":-3.282947,"marketCap":4680134848},{"date":"2024-08-30","current":-10.200908,"twenty":-15.468081,"median":-10.298317,"eighty":-3.282947,"marketCap":4629366009},{"date":"2024-09-06","current":-12.968661,"twenty":-15.406372,"median":-10.298317,"eighty":-3.282947,"marketCap":5885424699},{"date":"2024-09-13","current":-11.166307,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5067482289},{"date":"2024-09-20","current":-11.116587,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5044918360},{"date":"2024-09-27","current":-10.142902,"twenty":-15.346079,"median":-10.291437,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-10-04","current":-10.619386,"twenty":-15.346079,"median":-10.287903,"eighty":-3.282947,"marketCap":4819279074},{"date":"2024-10-11","current":-10.341782,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-10-18","current":-10.851413,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4924577408},{"date":"2024-10-25","current":-10.014458,"twenty":-15.346079,"median":-10.247312,"eighty":-3.282947,"marketCap":4544751277},{"date":"2024-10-31","current":-9.857011,"twenty":-15.346079,"median":-10.213164,"eighty":-3.282947,"marketCap":4473298837},{"date":"2024-11-08","current":-10.722969,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4866287259},{"date":"2024-11-15","current":-10.382683,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4556544126},{"date":"2024-11-22","current":-10.008028,"twenty":-15.271599,"median":-10.197026,"eighty":-3.280616,"marketCap":4392122998},{"date":"2024-11-29","current":-11.665984,"twenty":-15.218244,"median":-10.186868,"eighty":-3.280616,"marketCap":5119733736},{"date":"2024-12-06","current":-11.48081,"twenty":-15.156078,"median":-10.186868,"eighty":-3.280616,"marketCap":5038468121},{"date":"2024-12-13","current":-11.915754,"twenty":-15.091844,"median":-10.186868,"eighty":-3.280616,"marketCap":5229347821},{"date":"2024-12-20","current":-11.287023,"twenty":-14.973758,"median":-10.186868,"eighty":-3.280616,"marketCap":4953422710},{"date":"2024-12-27","current":-12.225813,"twenty":-14.909796,"median":-10.186868,"eighty":-3.280616,"marketCap":5365420478},{"date":"2025-01-03","current":-12.143992,"twenty":-14.881378,"median":-10.186868,"eighty":-3.280616,"marketCap":5329512416},{"date":"2025-01-10","current":-12.68229,"twenty":-14.811419,"median":-10.183098,"eighty":-3.278285,"marketCap":5565749668},{"date":"2025-01-17","current":-14.689063,"twenty":-14.775692,"median":-10.183098,"eighty":-3.278285,"marketCap":6446442146},{"date":"2025-01-24","current":-15.972364,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":7009631756},{"date":"2025-01-31","current":-15.49005,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":6797963177},{"date":"2025-02-07","current":-14.081863,"twenty":-14.698128,"median":-10.183098,"eighty":-3.278285,"marketCap":6179966525},{"date":"2025-02-14","current":-13.590936,"twenty":-14.67161,"median":-10.183098,"eighty":-3.278285,"marketCap":5964518151},{"date":"2025-02-21","current":-12.982947,"twenty":-14.658475,"median":-10.183098,"eighty":-3.278285,"marketCap":6955769662},{"date":"2025-02-28","current":-12.15831,"twenty":-14.555662,"median":-10.183098,"eighty":-3.278285,"marketCap":6513960440},{"date":"2025-03-07","current":-11.441236,"twenty":-14.509608,"median":-10.179327,"eighty":-3.275954,"marketCap":6129779415},{"date":"2025-03-14","current":-11.469635,"twenty":-14.509608,"median":-10.186868,"eighty":-3.275954,"marketCap":6144994506},{"date":"2025-03-21","current":-12.037614,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6449296307},{"date":"2025-03-28","current":-12.921532,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6922865986},{"date":"2025-04-04","current":-12.094412,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6479726487},{"date":"2025-04-11","current":-11.469635,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6144994506},{"date":"2025-04-17","current":-12.016315,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6437884990},{"date":"2025-04-25","current":-12.765338,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6839182990},{"date":"2025-05-02","current":-10.915822,"twenty":-14.487131,"median":-10.207344,"eighty":-3.275954,"marketCap":7291419648},{"date":"2025-05-09","current":-9.906677,"twenty":-14.440661,"median":-10.200908,"eighty":-3.275954,"marketCap":6617343092},{"date":"2025-05-16","current":-9.591141,"twenty":-14.390691,"median":-10.17585,"eighty":-3.275954,"marketCap":6406575492},{"date":"2025-05-23","current":-9.372256,"twenty":-14.253095,"median":-10.142902,"eighty":-3.275954,"marketCap":6260367338},{"date":"2025-05-30","current":-9.485963,"twenty":-14.231346,"median":-10.123196,"eighty":-3.275954,"marketCap":6336319626},{"date":"2025-06-06","current":-10.898766,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7280026804},{"date":"2025-06-13","current":-11.271155,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7528770548},{"date":"2025-06-20","current":-11.370648,"twenty":-14.232499,"median":-10.113252,"eighty":-3.273623,"marketCap":7595228800},{"date":"2025-06-27","current":-12.826091,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8567418086},{"date":"2025-07-03","current":-12.50487,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8352852872},{"date":"2025-07-11","current":-13.152997,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8785780914},{"date":"2025-07-18","current":-13.286602,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8875024852},{"date":"2025-07-25","current":-12.979594,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8669953675},{"date":"2025-08-01","current":-13.437263,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8975661634},{"date":"2025-08-08","current":-11.313785,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8784192758},{"date":"2025-08-15","current":-12.601513,"twenty":-14.224806,"median":-10.122691,"eighty":-3.273623,"marketCap":9784004034},{"date":"2025-08-22","current":-12.367605,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":9602393955},{"date":"2025-08-29","current":-12.943758,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":10049728255},{"date":"2025-09-05","current":-12.761556,"twenty":-14.227887,"median":-10.142902,"eighty":-3.271292,"marketCap":9908263562},{"date":"2025-09-12","current":-12.951145,"twenty":-14.224806,"median":-10.142902,"eighty":-3.273623,"marketCap":10055463310},{"date":"2025-09-19","current":-13.130885,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10195016318},{"date":"2025-09-26","current":-12.064755,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":9367256696},{"date":"2025-10-03","current":-13.118574,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10185457893},{"date":"2025-10-10","current":-13.490366,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"marketCap":10474122334},{"date":"2025-10-17","current":-13.549458,"twenty":-14.200393,"median":-10.142902,"eighty":-3.273623,"marketCap":10520002775},{"date":"2025-10-24","current":-13.249071,"twenty":-14.188391,"median":-10.142902,"eighty":-3.273623,"marketCap":10286777200},{"date":"2025-10-31","current":-15.320138,"twenty":-14.229418,"median":-10.142902,"eighty":-3.273623,"marketCap":12211957479},{"date":"2025-11-07","current":-15.165413,"twenty":-14.383346,"median":-10.142902,"eighty":-3.273623,"marketCap":12088623839},{"date":"2025-11-14","current":-15.728707,"twenty":-14.522102,"median":-10.142902,"eighty":-3.273623,"marketCap":12537635373},{"date":"2025-11-21","current":-15.622334,"twenty":-14.662972,"median":-10.142902,"eighty":-3.273623,"marketCap":12452843496},{"date":"2025-11-28","current":-17.408918,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":13876961624},{"date":"2025-12-05","current":-18.073749,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14406910859},{"date":"2025-12-12","current":-17.905728,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14272978234},{"date":"2025-12-19","current":-17.92386,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14287431395},{"date":"2025-12-26","current":-18.501659,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14748005458},{"date":"2026-01-02","current":-18.491989,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14740297106},{"date":"2026-01-09","current":-17.846498,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14225764575},{"date":"2026-01-16","current":-18.436385,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14695974079},{"date":"2026-01-23","current":-19.318798,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":15399361246},{"date":"2026-01-30","current":-19.122974,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":15243267108},{"date":"2026-02-06","current":-15.40717,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":12281332652},{"date":"2026-02-13","current":-18.388033,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14657432316},{"date":"2026-02-20","current":-17.097051,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":13628367255},{"date":"2026-02-27","current":-18.080436,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":13107068708},{"date":"2026-03-06","current":-17.695348,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":12827906174},{"date":"2026-03-13","current":-18.179383,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":13178797970},{"date":"2026-03-20","current":-18.738296,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":13583971370},{"date":"2026-03-27","current":-19.409526,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14070567177},{"date":"2026-04-02","current":-19.909606,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14433090745},{"date":"2026-04-10","current":-20.195748,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":14640524017},{"date":"2026-04-15","current":-20.840237,"twenty":-14.682228,"median":-10.142902,"eighty":-3.273623,"marketCap":15107733537}],"updateTime":1776402127915},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627626707","title":"U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2627626707","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627626707?lang=en_us&edition=fundamental","pubTime":"2026-04-16 15:55","pubTimestamp":1776326124,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial ServicesApril 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nL4N40Z0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DLLL","AMT","GLW","KMX","AWK","CZR","ALLO","AMD","APH","BBIO","AMDU","ANET","CME","OBDC","CALX","CSCS","USJW.SI","AMDY","CLH","AMDG","BXMT","CENX","COF","CE","BFH","AEP","COTG","DOGD","CHDN","BAC","DELL","GOOG","COST","CSCO","BYD","DAMD","ALNY","ARCB","AXPG","AXP","AESI","CIEN","DDOG","ACRS","AXON","BP","CRUS","DHI","BPH","FIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627999469","title":"BridgeBio CEO Neil Kumar disposes of USD 5,819,364 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627999469","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627999469?lang=en_us&edition=fundamental","pubTime":"2026-04-14 06:06","pubTimestamp":1776118006,"startTime":"0","endTime":"0","summary":"BridgeBio CEO Neil Kumar reported sales of 79,000 BridgeBio common shares on April 9-10.Sales were executed at weighted average prices ranging from USD 73.64 to USD 75.55 per share.Holdings in trusts linked to Kumar fell to 595,686 shares in Kumar Haldea Family Irrevocable Trust.Holdings in Kumar Haldea Revocable Trust declined to 4,398,447 shares.Kumar also reported direct ownership of 234,451 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL62hhrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BridgeBio CEO Neil Kumar disposes of USD 5,819,364 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BBIO","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627463400","title":"BridgeBio Oncology Therapeutics grants inducement stock options for 32,675 shares at $8.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2627463400","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627463400?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:06","pubTimestamp":1776110815,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics issued inducement equity awards on April 10, 2026 to one employee hired in March 2026.Award consisted of non-qualified stock options covering 32,675 shares with an exercise price of $8.4.Options vest 25% on first anniversary of employee start date.Remaining options vest in 36 equal monthly installments, subject to continued service.Grants were made under BBOT 2025 Inducement Plan adopted in October 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL1CBcBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014005.SGD","BK4505","IE00B64PRP62.GBP","BBOT","LU2210150020.SGD","BK4139","SG9999014013.SGD","IE00BGHQF748.EUR","BK4585","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","LU0314104364.USD","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","IE00BN0W2V16.EUR","NDAQ","SG9999014021.USD","LU2210149790.SGD","BBIO","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627743564","title":"Assessing BridgeBio Pharma (BBIO) Valuation After Key ATTR-CM And LGMD2I/R9 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2627743564","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627743564?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:17","pubTimestamp":1776068253,"startTime":"0","endTime":"0","summary":"Why BridgeBio Pharma is back on investor radars\nBridgeBio Pharma (BBIO) has drawn fresh attention after releasing long-term data for its ATTR-CM drug acoramidis and filing an FDA New Drug Application for BBP-418 in limb-girdle muscular dystrophy.\nThese product updates, together with new analyst coverage highlighting BridgeBio's broader rare disease pipeline, have refocused the market on how its existing approvals and late-stage programs might shape the company’s future profile.\nSee our latest...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bbio/bridgebio-pharma/news/assessing-bridgebio-pharma-bbio-valuation-after-key-attr-cm","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bbio/bridgebio-pharma/news/assessing-bridgebio-pharma-bbio-valuation-after-key-attr-cm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBIO","BK4588","BK4505","CM","BK4585","BK4139","ATTR","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143730","title":"Southwest Airlines, Colliers International, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143730","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143730?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:28","pubTimestamp":1775856480,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from April 2 through April 8, 2026. Source: VerityData. Alkami Technology Jana Partners Management disclosed a new position in the digital banking software company of 5,431,388 shares. Jana purchased 536,723 Alkami Technology shares from Feb. 26 through March 25 at per share prices ranging from $14.96 to $16.08. Following the latest purchases, Jana owns an initial 5.1% stake in Alkami Technology's outstanding stock. Shares of Alkami Technology have lost roughly 27.5% of their value in 2026.Cogent Biosciences Fairmount Funds Management lowered its stake in the biotechnology company to 15,356,918 shares. Fairmount Funds did so through the sale of seven million Cogent Biosciences shares through a block t","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4585","BK4588","BK4079","BK4211","LUV","MLTX","CIGI","BK4008","BBIO","ISBC","ALKT","BK4500","BK4505","BK4023","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626344761","title":"Sector Update: Health Care Stocks Advance in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2626344761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626344761?lang=en_us&edition=fundamental","pubTime":"2026-04-10 01:50","pubTimestamp":1775757004,"startTime":"0","endTime":"0","summary":"Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.4%.The iShares Biotechnology ETF  rose 0.4%.In corporate news, Amazon.com's  Amazon Pharmacy said Thursday it is offering Eli Lilly's  obesity pill Foundayo. Additionally, WW International  said Thursday it is now offering access to Foundayo for weight loss through its Med+ program and affiliated medical groups. Lilly shares added 1%.BridgeBio Pharma  is transitioning from a single-asset transthyretin story into a diversified rare disease company, with growth poised to accelerate beyond its ATTR franchise, RBC Capital said in a note. RBC started coverage of the company with an outperform rating and a price target of $100. BridgeBio shares rose 1.3%.Vanda Pharmaceuticals  said Thursday it is calling on the US Food and Drug Administration to withdraw a proposal in the regulator's fiscal 2027 Congressional Budget Justification that would","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXQ63.HKD","IE00BK4W5M84.HKD","LU0162691827.USD","LU0072462426.USD","BK4538","LU2250418816.HKD","IE00BJJMRZ35.SGD","BK4561","LU0985320562.USD","LU0648000940.SGD","LU1429558221.USD","LU0061474960.USD","LU1791710400.SGD","LU2247934214.USD","LU1880398471.USD","LU2275660780.HKD","LU2317271919.USD","LU0456855351.SGD","LU1935042991.SGD","IE0001KFT4U8.USD","BK4592","LU2403377893.USD","LU0238689110.USD","LU1280957306.USD","LU2552382132.HKD","LU0215105999.USD","LU1551013425.SGD","LABU","LU0788109477.HKD","LU0345769631.USD","LU0528227936.USD","LU1244550494.USD","BK4596","LU2360032135.SGD","BK4598","LU1435385759.SGD","LU0882574139.USD","BK4579","LU0889565833.HKD","LU0786609619.USD","LU0345768153.USD","LU2750360997.AUD","LU2487616109.SGD","LU1201861249.SGD","BK4588","IE00B4JS1V06.HKD","SG9999014906.USD","LU2361045086.USD","LU1093756168.USD","LU1712237335.SGD","LU2456880835.USD","BK4507","IE00B7SZLL34.SGD","LU0080751232.USD","LU0820561909.HKD","LU0354030511.USD","LU0648001328.SGD","BK4612","LU0302445910.USD","LU2213496289.HKD","LU0234572021.USD","LU1988902786.USD","BK4566","IE00BKPKM429.USD","IE00BQXX3F31.USD","LU2054465674.USD","LU1633808545.USD","IE0004091025.USD","LU0642271901.SGD","HK0000914660.USD","LU0265550359.USD","LU0289960550.SGD","BK4505","IE00B19Z3581.USD","IE00BJLML261.HKD","LU1935043536.SGD","LU2087625088.SGD","LU2168564149.EUR","LU2602419157.SGD","IE0009355771.USD","LU0056508442.USD","SG9999001176.SGD","IE000YTNTUN2.SGD","LU2896262040.SGD","LU2237957902.USD","LLY","LU2211815571.USD","AMZU","IE00BFSS8Q28.SGD","LLII","LU2106854487.HKD","LU2746668974.SGD","SG9999001176.USD","LU0158827781.USD","LU2271345857.HKD","IE0004086264.USD","LU1201861165.SGD","LU0345770308.USD","LU0061474705.USD","LU2360106947.USD","LU2860962120.EUR","BK4503","IE00BN29S564.USD","LU0823416689.USD","LU2764262908.HKD","LU1066051225.USD","IE0004445015.USD","LU0417517546.SGD","LU1778281490.HKD","AMZP","LU1069344957.HKD","GB00BDT5M118.USD","LU0251132253.USD","IE00BQXX3D17.EUR","LU1267930730.SGD","LU0345774631.USD","LU0353189680.USD","LU1116320737.USD","LU2028103732.USD","LU2750360641.GBP","IE0004445239.USD","LU2764263203.CNY","IE0003U64NQ7.SGD","LU0345769128.USD","LU2756315318.SGD","LLYZ","LU2362540622.SGD","IE000ITXATA3.USD","IE00B19Z9505.USD","ELIL","SG9999002232.USD","IE000MB6IJN5.SGD","LU0965509101.SGD","LU0210533765.USD","LU2430703251.USD","AMZY","BBIO","LU1267930573.SGD","LU2065169927.USD","XBI","LU1934455277.USD","LU0097036916.USD","LU0348723411.USD","LU2463028550.USD","LU0096364046.USD","LU0471298694.HKD","LU0345774391.USD","LU1244550577.SGD","LU2505996509.AUD","LU0082616367.USD","LU0965508806.USD","LU2063271972.USD","BK4220","IE00BMPRXN33.USD","LU0070302665.USD","BK4604","SG9999013999.USD","LU0208291251.USD","LU1037948897.HKD","LU1868837300.USD","LU2764263039.SGD","LU1861559042.SGD","LU1720051017.SGD","LU0211327993.USD","LU1868836757.USD","LU2720916845.USD","LU2097829019.USD","LU0672654240.SGD","ELIS","LU1814569148.SGD","LU1046421795.USD","IE00BK4W5L77.USD","LU0058720904.USD","LU1244550221.USD","LU0079474960.USD","LU1232071149.USD","LU0823434740.USD","LU2471134879.HKD","LU2452424414.USD","LU1074936037.SGD","IE00B19Z8W00.USD","SG9999000418.SGD","LU2092937148.SGD","LU1057294990.SGD","LU0314104364.USD","LU1989764748.USD","LU0149725797.USD","SG9999004303.SGD","LU2168564065.EUR","LU1868837136.USD","LU1839511570.USD","BK4007","LU2756315664.SGD","SG9999015986.USD","SG9999015978.USD","IE000W1ABFV2.USD","SG9999018857.SGD","SG9999014914.USD","LU0820561818.USD","IE00BKDWB100.SGD","LU1718418525.SGD","LU1935042215.USD","AMZZ","SG9999018865.SGD","LU2505996681.GBP","LU2552382058.USD","LU1153585028.USD","LU1066051811.HKD","LU0211328371.USD","IE00BJJMRY28.SGD","LU0943347566.SGD","LU0965509010.AUD","LU1917777945.USD","LU2023250330.USD","IE0009G5SDU7.USD","LU0345768740.USD","LU0823421416.USD","IE00BKVL7J92.USD","LU2092627202.USD","LU2417539215.USD","LU0289739699.SGD","VNDA","LU1366192091.USD","LU2065170008.USD","LU1852331112.SGD","IE0002141913.USD","LU0320765489.SGD","LU0127658192.USD","LU1629891620.HKD","LU1935043023.USD","LU0109391861.USD","LU0107464264.USD","BK4550","LU0130102774.USD","LU1084165304.USD","LU1066053197.SGD","LU0276348264.USD","LU0061475181.USD","LU2237438978.USD","SGXZ23171101.USD","LU0109394709.USD","LU2592432038.USD","LU0289941410.SGD","SGXZ51526630.SGD","IE0005OL40V9.USD","LU2361044865.SGD","IE00B1XK9C88.USD","IE00B19Z3B42.SGD","LU2491049909.HKD","LU0122379950.USD","IE00B775SV38.USD","LU2242649171.HKD","IE000F7OJYX1.SGD","IE00B1BXHZ80.USD","LU2265009873.SGD","LU2324357040.USD","LU1496350171.SGD","LU0432979614.USD","BK4599","LU0225283273.USD","LU1823568750.SGD","LU0070217475.USD","BK4535","IE00BFTCPJ56.SGD","IE00BMPRXR70.SGD","LU0210528500.USD","LU1868836591.USD","LU0154236417.USD","LU1880398554.USD","LU0048584097.USD","LU0109392836.USD","LU2430703178.SGD","IE00B4R5TH58.HKD","IE00BQXX3C00.GBP","LU0320765992.SGD","LU1235294995.USD","LU2089284900.SGD","LU2237957811.SGD","IE00BYQQ9H92.USD","LU2087621335.USD","LU2168564495.EUR","LU1261432733.SGD","LU0308772762.SGD","LU2125154778.USD","SG9999002224.SGD","LU1064131342.USD","LU1861127337.USD","LU1145028129.USD","LU1267930490.SGD","LU1548497426.USD","LU2491050071.SGD","LU2471134523.USD","LU0096362180.USD","LU0234570918.USD","LU2471134952.CNY","LU1934455863.HKD","LU1316542783.SGD","LU0823434583.USD","BK4534","IE00B5949003.HKD","SGXZ81514606.USD","LU0072461881.USD","IE00BJT1NW94.SGD","LU2491050154.USD","LU2112291526.USD","IE000WAW04H5.SGD","LU2362541273.HKD","IE00BWXC8680.SGD","BK4581","LU0267386448.USD","LU2089984988.USD","LU2236285917.USD","LU1868836914.USD","IE00B5TLWC47.USD","LU0210536198.USD","LU1914381329.SGD","LU2111349929.HKD","LU0157215616.USD","LU0094547139.USD","LU1291159041.SGD","BK4533","LU1127390331.HKD","SG9999001077.SGD","LU0128525929.USD","IE00BJJMRX11.SGD","LU0106261372.USD","LU1815333072.USD","LU0198837287.USD","LU0203201768.USD","IE00B3S45H60.SGD","SG9999015945.SGD","IE00BFXG0V08.USD","LU0266013472.USD","BK4554","LU0882574055.USD","IE000BZT7R73.USD","IE00B4YYXB79.USD","LU0353189763.USD","LU2237443465.HKD","LU0345770993.USD","LU0006306889.USD","LU1934455194.USD","LU2211817866.USD","LU0175139822.USD","LU2326559502.SGD","LU1861558580.USD","LU1791710582.SGD","LU0719512351.SGD","LU2065171311.SGD","LU2242650005.HKD","BK4122","IE00BJTD4V19.USD","LU1066051498.USD","LU2237443382.USD","IE000SO60NU8.SGD","LU0114720955.EUR","LU2552382215.SGD","IE00BFSS7M15.SGD","LU0861579265.USD","LU0323591593.USD","IE00B2B36J28.USD","LU0640476718.USD","LU2237443895.HKD","LU0471298777.SGD","LU1061106388.HKD","LU1366333091.USD","LU0342679015.USD","SGXZ99366536.SGD","LU1623119135.USD","BK4559","LU0980610538.SGD","LU1974910355.USD","LU2083900584.USD","LU0823411888.USD","LU2381873111.SGD","AMZD","LU0170899867.USD","LU1496350502.SGD","LU2108987350.USD","LU0689472784.USD","LU0708995401.HKD","LU1323610961.USD","LU0077335932.USD","LU2168563687.JPY","LU1804176565.USD","IE00BJTD4N35.SGD","LLYX","LU0130103400.USD","LU1023059063.AUD","IE00B7KXQ091.USD","LU0256863811.USD","LU0316494557.USD","LU0390134368.USD","LU2746668461.USD","BK4585","LU0029864427.USD","LU2543165471.USD","IE00B775H168.HKD","LU0820562030.AUD","LU1803068979.SGD","BK4192","IE000KEQY171.SGD","LU0957791311.USD","LU0158827948.USD","BK4524","IE00B3SWFQ91.USD","LU0053666078.USD","LU0708994859.HKD","LU1551013342.USD","BK4532","IE00BZ1G4Q59.USD","LU2065171402.SGD","LU2237443978.SGD","LU1674673691.USD","AMZW","LU2023250504.SGD","IE0000B7K699.USD","LU1116320901.HKD","LU0011850046.USD","LU1119994496.HKD","LU2089283258.USD","SGXZ31699556.SGD","BK4516","LU2362541513.USD","LU1989771016.USD","LU1983299246.USD","LU2237443549.SGD","LU2125154935.USD","SG9999017495.SGD","HK0000914686.HKD","LU1989764664.SGD","LU0494093205.USD","LU0724617625.USD","LU0310799852.SGD","LU0385154629.USD","IE0009356076.USD","USAW.SI","BK4527","LU2077746001.SGD","LU0203202063.USD","LU2461242641.AUD","LU2023250843.SGD","LU2420271590.USD","LU0965509283.SGD","LU1674673428.USD","LU2361044949.HKD","LU0787776722.HKD","AZYY","LU0466842654.USD","LU0138981039.USD","SG9999015952.SGD","LU2168564222.USD","SGXZ57979304.SGD","LU1691799644.USD","IE0034235303.USD","SG9999014880.SGD","SG9999014898.SGD","LU2357305700.SGD","LU0964807845.USD","BK4548","LU2468319806.SGD","LU0823421333.USD","LU0312595415.SGD","XLV","LU0265550946.USD","LU1037948541.HKD","LU0310800379.SGD","BK4551","IE0002270589.USD","WW","BK4139","LU1720051108.HKD","LU0889565916.HKD","BK4543","IE00B19Z8X17.USD","LU2264538146.SGD","LU0354030438.USD","LU0320765059.SGD","LU2462157665.USD","LU1883839398.USD","LU0256863902.USD","LU2430703095.HKD","LU2237443622.USD","AMZN","LU1035775433.USD","LU1093756325.SGD","LU2360106780.USD","LU2023251221.USD","LU2471134796.USD","LU1935042488.USD","LU0683600562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626136590","title":"BridgeBio Pharma Evolving Into Rare Disease Powerhouse From TTR Roots, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2626136590","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626136590?lang=en_us&edition=fundamental","pubTime":"2026-04-09 23:25","pubTimestamp":1775748325,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma  is transitioning from a single-asset transthyretin story into a diversified rare disease company, with growth poised to accelerate beyond its ATTR franchise, RBC Capital said in a Wednesday note.RBC said Attruby is gaining early traction based on physician feedback and expects peak sales of around $3 billion. It added that while legal disputes over tafamidis remain an overhang, near-term generic risk to Vyndamax appears limited, and any longer-term impact should be manageable.Beyond TTR, RBC sees BridgeBio's broader pipeline as a key value driver, projecting more than $2 billion in additional peak revenue from assets including infigratinib, encaleret, and BBP-418. The firm believes the portfolio is underappreciated and could help lift total revenue to around $5 billion with strong margins.RBC also highlighted sustainability factors such as clinical trial practices, data transparency, and management diversity, noting the company is improving its governance and aligning","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBIO","BK4588","BK4505","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626003183","title":"RBC Initiates BridgeBio Pharma at Outperform, Speculative Risk With $100 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2626003183","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626003183?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:25","pubTimestamp":1775730325,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma (BBIO) has an average rating of buy and mean price target of $102.95, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BBIO","BK4585","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623258047","title":"Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623258047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623258047?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:20","pubTimestamp":1774966808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXT...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-60-degrees-pharmaceuticals-inc-sxtp-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-danaher-dhr-60-degrees-pharmaceuticals-inc-sxtp-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","HCSG","IE000M9KFDE8.USD","LU0289961442.SGD","LU0882574055.USD","LU2125910336.SGD","LABU","IE0004445239.USD","LU0114720955.EUR","LU2106854487.HKD","LU0312595415.SGD","LU1366333091.USD","LU1023059063.AUD","SG9999013999.USD","BK4007","LU0528227936.USD","SXTP","SG9999001176.USD","LU0689472784.USD","LU1974910355.USD","SGXZ23171101.USD","BK4139","LU0390134368.USD","LU2125909247.SGD","LU1057294990.SGD","DHR","LU2023250504.SGD","BK4137","LU2265009873.SGD","LU0289960550.SGD","BK4534","IE00BQXX3F31.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU2244417387.USD","LU1267930730.SGD","BK4504","BK4585","LU0820562030.AUD","LU0122379950.USD","IE00BQXX3C00.GBP","LU0029874061.USD","XLV","SG9999001176.SGD","LU0672654240.SGD","LU0820561818.USD","LU1791710400.SGD","XBI","BBIO","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623531326","title":"BridgeBio presentation shows acoramidis cuts all-cause mortality risk 45% in ATTR-CM trial extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2623531326","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623531326?lang=en_us&edition=fundamental","pubTime":"2026-03-31 03:48","pubTimestamp":1774900136,"startTime":"0","endTime":"0","summary":"BridgeBio published medical research presentation on long-term outcomes from ATTRibute-CM open-label extension evaluating acoramidis in transthyretin amyloid cardiomyopathy through Month 54.Continuous acoramidis cut risk of all-cause mortality composite by 45% vs placebo through Month 54; hazard ratio 0.55 .Continuous acoramidis reduced risk of cardiovascular-related mortality by 49% vs placebo through Month 54; hazard ratio 0.51 .Data showed NT-proBNP stabilized with continuous acoramidis through Month 54.Safety results showed treatment-emergent serious adverse events in 47.9% of continuous acoramidis group during Month 30-54 open-label period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL5DdTC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBIO","BK4139","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623250753","title":"BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2623250753","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623250753?lang=en_us&edition=fundamental","pubTime":"2026-03-31 03:40","pubTimestamp":1774899637,"startTime":"0","endTime":"0","summary":"BridgeBio (BBIO) presented long-term efficacy and safety data from the ATTRibute-CM open-label extension trial, demonstrating sustained clinical be...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-presents-long-term-efficacy-safety-data-from-attribute-cm-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-presents-long-term-efficacy-safety-data-from-attribute-cm-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4585","BK4139","CM","BK4505","BBIO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623444983","title":"BridgeBio presents long-term acoramidis data showing sustained sTTR gains, stable KCCQ scores","url":"https://stock-news.laohu8.com/highlight/detail?id=2623444983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623444983?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:34","pubTimestamp":1774884886,"startTime":"0","endTime":"0","summary":"BridgeBio published long-term open-label extension results for acoramidis in transthyretin amyloid cardiomyopathy, tracking serum transthyretin levels and Kansas City Cardiomyopathy Questionnaire Overall Summary scores through month 54.Continuous acoramidis use maintained higher serum transthyretin, with mean change from baseline of 8 mg/dL at month 54.Patients switched from placebo to acoramidis showed rapid serum transthyretin increase by month 31, with mean change from baseline of 7.4 mg/dL.Health-status scores were reported as stabilized through month 54, with mean change from baseline of -4.8 points for continuous treatment.Placebo-to-acoramidis group showed mean change from baseline of -12.5 points in KCCQ-OS at month 54.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLb5xPyT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BBIO","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623034449","title":"BridgeBio presents US survey showing high ATTR-CM treatment dissatisfaction, oral dosing preferred","url":"https://stock-news.laohu8.com/highlight/detail?id=2623034449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623034449?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:34","pubTimestamp":1774884876,"startTime":"0","endTime":"0","summary":"BridgeBio published results from a US real-world survey on treatment patterns and preferences in transthyretin amyloid cardiomyopathy .Survey found 60.5% of patients were on prescribed ATTR therapy at time of assessment; 32.8% had never received prescribed treatment.Physicians reported they were not fully satisfied with treatment for 56.1% of treated patients, citing limited symptom control or limited impact on disease progression.Patients reported dissatisfaction with current therapy, with 71.9% less than “very happy,” driven mainly by cost concerns or expectations of greater improvement.Patient preference skewed to oral therapy, with 100% reporting comfort with once- or twice-daily oral medication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or le","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLTsZm0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","BK4585","BK4139","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623762312","title":"BridgeBio submits BBP-418 NDA to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2623762312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623762312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:56","pubTimestamp":1774871788,"startTime":"0","endTime":"0","summary":"BridgeBio (BBIO) announced the submission of its new drug application to the FDA for oral BBP-418 for the treatment of individuals living with limb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-submits-bbp-418-nda-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-submits-bbp-418-nda-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4505","BBP","BBIO","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623496314","title":"BridgeBio submits FDA NDA for BBP-418 in LGMD2I/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2623496314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623496314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:32","pubTimestamp":1774870355,"startTime":"0","endTime":"0","summary":"BridgeBio submitted New Drug Application to FDA seeking approval of oral BBP-418 for limb-girdle muscular dystrophy type 2I/R9.Filing included interim Phase 3 FORTIFY data showing statistically significant improvements in ambulation and pulmonary function.Company expects FDA decision to support U.S. launch in late 2026 or early 2027.Fast Track status could make application eligible for Priority Review.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLbk9W50:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","BBIO","SG9999014005.SGD","LU2210149790.SGD","BK4139","IE00BN0W2T93.GBP","BK4505","LU0314104364.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","NDAQ","BK4588","BK4585","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623314117","title":"BridgeBio Pharma Inc - IF Approved, BridgeBio May Qualify for Priority Review Voucher","url":"https://stock-news.laohu8.com/highlight/detail?id=2623314117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623314117?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA1RGKCD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BBIO","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623199314","title":"BridgeBio Pharma Inc - Anticipates U.S. Launch of Bbp-418 in Late 2026/Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2623199314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623199314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA1RGKCD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4505","BK4585","BK4139","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623141123","title":"BridgeBio Submits Nda to FDA for Bbp-418 for Individuals Living With Lgmd2i/R9","url":"https://stock-news.laohu8.com/highlight/detail?id=2623141123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623141123?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA1RGKCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BBIO","BK4139","BK4505","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622899007","title":"BridgeBio Oncology Therapeutics appoints Peter Lebowitz to board; board size increases to nine directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899007","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899007?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:53","pubTimestamp":1774558381,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics increased its board size to nine directors and appointed Peter Lebowitz as a Class I director.Peter Lebowitz was also appointed to the Nominating and Corporate Governance Committee and the Compensation Committee.His term expires at the 2026 annual meeting of stockholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3GDLz4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BBOT","BK4505","BK4139","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770796","title":"BridgeBio to present long-term ATTRibute-CM open-label extension data on acoramidis at ACC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770796?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:31","pubTimestamp":1774265463,"startTime":"0","endTime":"0","summary":"BridgeBio reported that long-term efficacy and safety data from the open-label extension  of its Phase 3 ATTRibute-CM trial of acoramidis in patients with transthyretin amyloid cardiomyopathy  will be presented at the ACC Annual Scientific Sessions & Expo on March 30, 2026 by Prem Soman.Additional OLE findings on serum transthyretin concentrations and Kansas City Cardiomyopathy Questionnaire Overall Summary  scores are scheduled for poster presentation on March 28, 2026 by Sarah Cuddy.Another poster will present results on the association between early increases in serum transthyretin with acoramidis and long-term heart failure-related health status in ATTR-CM on March 28, 2026 by Jan Griffin.A separate poster will present results from a US real-world survey on ATTR-CM treatment patterns and preferences on March 30, 2026 by Jill Waldron.BridgeBio said diarrhea occurred in 11.6% of patients receiving Attruby versus 7.6% with placebo, and upper abdominal pain occurred in 5.5% versus 1.4%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL9jKMGm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4505","SG9999014021.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","BK4112","BBIO","BK4588","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014005.SGD","NDAQ","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}]}}